BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhen H, Li G, Zhao P, Zhang Y, Wang J, Yu J, Cao B. Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways. Onco Targets Ther 2020;13:12325-39. [PMID: 33293826 DOI: 10.2147/OTT.S276125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng ZY, Chu MY, Lin W, Zheng YQ, Xu XE, Chen Y, Liao LD, Wu ZY, Wang SH, Li EM, Xu LY. Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma. Cell Death Dis 2022;13:496. [PMID: 35614034 DOI: 10.1038/s41419-022-04941-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]